The American Academy of Family Physicians supports full disclosure to physicians and patients of corporate ties and financial relationships between pharmaceutical manufacturers, mail order pharmacies, pharmacy benefit management entities and pharmacists. Additionally, formulary decisions and “drug switching” should not be based principally on financial considerations, but on evidence-based therapeutic and quality of care considerations, to promote optimal patient care. (1998) (October 2025 COD)